DK225579A - Imidazo (2,1-b)-(1,3,4)-thiadiazoler deres fremstilling og anvendelse - Google Patents

Imidazo (2,1-b)-(1,3,4)-thiadiazoler deres fremstilling og anvendelse

Info

Publication number
DK225579A
DK225579A DK225579A DK225579A DK225579A DK 225579 A DK225579 A DK 225579A DK 225579 A DK225579 A DK 225579A DK 225579 A DK225579 A DK 225579A DK 225579 A DK225579 A DK 225579A
Authority
DK
Denmark
Prior art keywords
imidazo
thiadiazoles
preparation
compounds
agents
Prior art date
Application number
DK225579A
Other languages
English (en)
Inventor
H Horstmann
I H F Meng
M Meng
F Seuter
E Moeller
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK225579A publication Critical patent/DK225579A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Lubricants (AREA)
  • Detergent Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK225579A 1978-05-31 1979-05-30 Imidazo (2,1-b)-(1,3,4)-thiadiazoler deres fremstilling og anvendelse DK225579A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782823686 DE2823686A1 (de) 1978-05-31 1978-05-31 Imidazo eckige klammer auf 2.1-b eckige klammer zu eckige klammer auf 1.3.4 eckige klammer zu -thiadiazole

Publications (1)

Publication Number Publication Date
DK225579A true DK225579A (da) 1979-12-01

Family

ID=6040588

Family Applications (1)

Application Number Title Priority Date Filing Date
DK225579A DK225579A (da) 1978-05-31 1979-05-30 Imidazo (2,1-b)-(1,3,4)-thiadiazoler deres fremstilling og anvendelse

Country Status (12)

Country Link
US (1) US4265898A (da)
EP (1) EP0005783B1 (da)
JP (1) JPS54157564A (da)
AT (1) ATE512T1 (da)
AU (1) AU523229B2 (da)
CA (1) CA1128941A (da)
DE (2) DE2823686A1 (da)
DK (1) DK225579A (da)
ES (1) ES481155A1 (da)
FI (1) FI66390C (da)
HU (1) HU179411B (da)
IL (1) IL57420A (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444770A (en) * 1980-05-29 1984-04-24 Bayer Aktiengesellschaft New imidazoazole-alkenoic acid amide compounds, intermediate products for their production, their production, and their medicinal use
IT8148047A0 (it) * 1981-03-18 1981-03-18 Manetti & Roberts Italo Brit Composti organici derivati da 2-ami no-5-(o-solfamidofenil)-1,3,4-tiadiazolo loro applicazione terapeutica e procedimento per la loro preparazione
DE3208437A1 (de) * 1982-03-09 1983-09-15 Bayer Ag, 5090 Leverkusen Imidazothiadiazolalkencarbonsaeureamide, neue zwischenprodukte zu ihrer herstellung, ihre herstellung und ihre verwendung in arzneimitteln
US4968494A (en) * 1987-03-27 1990-11-06 Merck & Co., Inc. Methods and compositions for thrombolytic therapy
US5019572A (en) * 1990-02-07 1991-05-28 Merck & Co., Inc. Imidazole compounds and their use as transglutaminase inhibitors
US5030644A (en) * 1989-07-31 1991-07-09 Merck & Co., Inc. Imidazole compounds and their use as transglutaminase inhibitors
US5047416A (en) * 1989-07-31 1991-09-10 Merck & Co., Inc. Triazole compounds and their use as transglutaminase inhibitors
US4968713A (en) * 1989-07-31 1990-11-06 Merck & Co., Inc. Certain imidazole compounds as transglutaminase inhibitors
US5021440A (en) * 1989-07-31 1991-06-04 Merck & Co., Inc. Imidazole compounds and their use as transglutaminase inhibitors
US5077285A (en) * 1989-07-31 1991-12-31 Merck & Co., Inc. Imidazole compounds and their use as transglutaminase inhibitors
US8173661B2 (en) 2006-11-08 2012-05-08 The Rockefeller University Alpha-IIB-beta-3 inhibitors and uses thereof
AU2011279008B2 (en) 2010-07-16 2016-06-23 Icahn School Of Medicine At Mount Sinai Organic compounds
WO2013109632A2 (en) * 2012-01-16 2013-07-25 The Rockefeller University Organic compounds
BR112014026643B1 (pt) * 2012-04-26 2023-03-07 Universite De Montreal Derivados de imidazotiadiazol e imidazopirazina como inibidores de receptor 4 ativado por protease (par4) para o tratamento de agregação de plaqueta, seus usos e composição farmacêutica
EP2855489B1 (en) 2012-04-26 2017-01-04 Bristol-Myers Squibb Company Imidazothiadiazole and imidazopyridazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
KR20150003767A (ko) 2012-04-26 2015-01-09 브리스톨-마이어스 스큅 컴퍼니 혈소판 응집을 치료하기 위한 프로테아제 활성화 수용체 4 (par4) 억제제로서의 이미다조티아디아졸 유도체
EP2682395A1 (en) * 2012-07-04 2014-01-08 Laboratorios Del. Dr. Esteve, S.A. Imidazo[2,1-b]thiazole derivatives, their preparation and use as medicaments
US9598419B1 (en) 2014-06-24 2017-03-21 Universite De Montreal Imidazotriazine and imidazodiazine compounds
US9617279B1 (en) 2014-06-24 2017-04-11 Bristol-Myers Squibb Company Imidazooxadiazole compounds
WO2017184520A1 (en) * 2016-04-18 2017-10-26 Vanderbilt University Substituted and fused 6-membered protease activated receptor 4 (par-4) antagonists
CN112074522B (zh) * 2018-05-16 2022-08-26 深圳信立泰药业股份有限公司 作为用于治疗血小板聚集的蛋白酶激活受体4(par4)抑制剂的化合物
WO2019218956A1 (zh) * 2018-05-16 2019-11-21 深圳信立泰药业股份有限公司 作为用于治疗血小板聚集的蛋白酶激活受体4(par4)抑制剂的化合物
EP3810134A4 (en) 2018-06-19 2022-03-30 Celecor Therapeutics, Inc. DEUTERED RUC-4
WO2023093700A1 (zh) * 2021-11-29 2023-06-01 中国海洋大学 咪唑并噻唑衍生物及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3726891A (en) * 1970-12-02 1973-04-10 Shell Oil Co Fused 1,2,4-thiadiazolines
US3804823A (en) * 1972-02-15 1974-04-16 Eastman Kodak Co Heterocyclic containing monoazo compounds
GB1464259A (en) * 1975-10-03 1977-02-09 Pfizer Ltd Imidazo-thiazole and -thiadiazole sulphonamides and their use as therapeutic agents
US4042372A (en) * 1976-11-19 1977-08-16 Eli Lilly And Company Substituted thiadiazolotriazinediones and method of preparation

Also Published As

Publication number Publication date
FI66390B (fi) 1984-06-29
IL57420A (en) 1983-06-15
EP0005783B1 (de) 1981-12-30
EP0005783A1 (de) 1979-12-12
ATE512T1 (de) 1982-01-15
DE2961667D1 (en) 1982-02-18
FI791708A (fi) 1979-12-01
CA1128941A (en) 1982-08-03
FI66390C (fi) 1984-10-10
AU523229B2 (en) 1982-07-15
ES481155A1 (es) 1979-11-16
DE2823686A1 (de) 1979-12-06
AU4760679A (en) 1979-12-06
HU179411B (en) 1982-10-28
IL57420A0 (en) 1979-09-30
US4265898A (en) 1981-05-05
JPS54157564A (en) 1979-12-12

Similar Documents

Publication Publication Date Title
DK225579A (da) Imidazo (2,1-b)-(1,3,4)-thiadiazoler deres fremstilling og anvendelse
DK173883D0 (da) Substituerede 8-phenylxanthiner
NO158741C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kvartaere dibenzotiepin-n-alkyl-norskopinetere.
FI793689A (fi) Hydroxietyl-azoler foerfarande foer framstaellning av dem samt deras anvaendning som laekemedel
JPS55108860A (en) Hydroxypropylltriazole*its manufacture and use as medicine
IL64292A0 (en) D-homosteroids,their manufacture and pharmaceutical compositions containing them
IL58299A (en) Fluorine-containing 1,4-dihydropyridine derivatives,their production and their medicinal use
NO159851C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive svovelsubstituerte fenoxypyridiner.
FI813912L (fi) I laekemedel anvaendbara tricykliska cytosinderivat och foerfarande foer deras framstaellning
DK260180A (da) Pseudotrisaccharider deres fremstilling og anvendelse som antibakterielle midler
MX6274E (es) Procedimiento para la preparacion de composiciones parmaceuticas que contienen alcohilantes citostaticos destoxificados
JPS5573661A (en) Fluorenyllazolylmethyllcarbinol compound* its manufacture and its use as drug
FR2445838A1 (fr) Nouveaux 1a,3b-dihydroxy-5-steroides
DE3167565D1 (de) Anthelmintic imidazo(2,1-b)thiazole gel compositions
JPS57185270A (en) Novel cyclic sulfenamides, manufacture and use as drug
DK239084D0 (da) 2-alkylthio-1-aminoalkyl-2-pyrrolin-3-carbonitriler